肾移植失功后再移植障碍的定性研究:患者、照护者与供者视角
本研究采用解释性描述定性设计,对23例肾移植失功患者、23名照护者及11名移植肾内科医生进行半结构化访谈,识别出再移植的四大医学与非医学障碍,以及活体供肾再移植的额外障碍,并强调系统、移植中心、供者与患者层面的应对策略。
要点
- 再移植障碍包括高致敏导致配型困难、合并症致不合格、不依从史及转诊延迟。
- 活体供肾再移植额外障碍包括患者偏好 deceased donor、供者池耗尽感及心理负担。
- 需系统、移植中心、供者与患者多层面干预以改善再移植可及性。
核心结论
- 再移植存在持续且叠加的医学与非医学障碍,需多层面干预。
研究设计与样本
- 解释性描述定性研究,纳入23例肾移植失功患者、23名照护者及11名移植肾内科医生,来自11个加拿大移植项目。
主要发现
- 再移植四大障碍:高抗体致敏致相容供者稀缺、合并症致不合格或退出等待、不依从史致不合格或转诊延迟、转诊延迟与再移植评估协调不佳。
- 活体供肾再移植额外障碍:患者偏好 deceased donor 且失功后难改变、感知合格活体供者池已在首次移植耗尽、既往活体供肾失功相关未解决心理负担、活体供肾捐献的结构性障碍。
临床怎么用
- 临床应关注高致敏、合并症、不依从史及转诊延迟等可干预障碍,优化再移植评估流程。
- 对活体供肾再移植,需评估患者偏好、供者池及心理负担,并提供结构性支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: This qualitative study explored patient, caregiver, and provider perceived barriers to retransplantation after kidney allograft loss. We identified four medical and nonmedical barriers to retransplantation and four additional barriers to pursuing living donor retransplantation. System-, transplant center-, provider-, and patient-level approaches to address these barriers are highlighted. BACKGROUND: Many kidney transplant recipients experience graft loss, and retransplantation offers a significant survival benefit when compared with waitlisted patients. Yet, trends related to preemptive relisting/retransplantation are suboptimal. Little empirical evidence has explored barriers to kidney retransplantation. We aimed to identify the predominant barriers to retransplantation after graft loss and factors that hinder the pursuit of living kidney donor (LKD) retransplantation. METHODS: This was a qualitative study that used an interpretive descriptive design. Participants included patients with a history of graft loss, caregivers who supported them, and transplant nephrologists, recruited using purposive and snowball sampling techniques. Data collection entailed semistructured interviews that were coded, and an inductive thematic analysis was conducted. RESULTS: We synthesized the perspectives of 23 patients, 23 caregivers, and 11 transplant nephrologists representing 11 Canadian transplant programs. Through our analysis, we identified four key barriers to retransplantation: high antibody sensitization resulting in scarcity of compatible donors; prevalence of comorbidities leading to ineligibility or wait list withdrawal; history of nonadherence among the recipients leading to ineligibility or delays in transplant referral and reevaluation; and delayed referrals and poor coordination of retransplant workup. Additional barriers to LKD retransplantation included patient preference for deceased donor transplantation that was unlikely to change after graft loss; perceived smaller pool of eligible LKDs felt to have been exhausted with the first transplant; the psychological burden of unresolved issues related to previous LKD transplant loss; and overall structural barriers to living kidney donation. CONCLUSIONS: This analysis highlights both medical and nonmedical barriers to retransplantation and that the pursuit of retransplantation entails persistent as well as additional and compounding challenges. A list of implications that arise from these findings is presented. Given the well-established benefits of kidney transplantation and that graft loss remains a leading cause of dialysis initiation, these findings have important implications for the nephrology community.
引用
- Slominska AM, Gouin-Bonenfant M, Katz E, et al. A Qualitative Study of Patients, Caregivers, and Providers on Barriers to Kidney Retransplantation following Graft Loss. Clin J Am Soc Nephrol. 2026. PMID: 42485104. doi:10.2215/CJN.0000001162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。